Clene (CLNN) Assets Average (2021 - 2026)
Clene (CLNN) posted Assets Average of $20.6 million for Q2 2026, up 1.81% on a QoQ basis from $20.2 million in Q4 2025, and down 13.21% year-over-year from $23.7 million in Q2 2025.
Analysis
Clene (CLNN) Assets Average (2021 - 2026) Analysis & Trends
Clene has reported Assets Average for 6 years, with the latest figure at $20.6 million in Q2 2026.
- On a quarterly basis, Assets Average fell 13.21% year-over-year to $20.6 million in Q2 2026; TTM through Jun 2026 was $20.6 million, a 13.21% decrease from a year earlier, with the FY2025 full-year figure at $22.7 million, down 42.94% from the prior year.
- Assets Average was $20.6 million for Q2 2026 at Clene, up from $20.2 million in the prior quarter.
- The five-year high for Assets Average was $64.1 million in Q3 2023, with the low at $20.2 million in Q4 2025.
- Average Assets Average over 5 years is $39.7 million, with a median of $40.3 million recorded in 2022.
- The sharpest annual moves came in 2023 and 2024: Assets Average jumped 59.26% in 2023, then plunged 47.77% in 2024.
- Over 5 years, Assets Average stood at $40.2 million in 2022, then surged by 40.1% to $56.4 million in 2023, then slumped by 47.77% to $29.5 million in 2024, then sank by 31.34% to $20.2 million in 2025, then climbed by 1.81% to $20.6 million in 2026.
- The last three Assets Average figures came in at $20.6 million (Q2 2026), $20.2 million (Q4 2025), and $22.2 million (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.14 Bn | 620.38 Bn | 17.26 Bn | 200.98 Bn |
| 2 | AbbVie | 451.04 Bn | 444.47 Bn | 12.70 Bn | 135.79 Bn |
| 3 | Merck | 357.43 Bn | 350.29 Bn | 12.21 Bn | 129.24 Bn |
| 4 | Novartis Ag | 266.73 Bn | 259.04 Bn | 11.24 Bn | 120.28 Bn |
| 5 | Pfizer | 157.52 Bn | 145.82 Bn | 10.94 Bn | 204.57 Bn |
| 6 | Sanofi | 52.14 Bn | 44.76 Bn | 10.79 Bn | 149.95 Bn |
| 7 | Revolution Medicines | 42.88 Bn | 42.88 Bn | - | 3.29 Bn |
| 8 | Incyte | 24.70 Bn | 20.16 Bn | 1.57 Bn | 7.61 Bn |
| 9 | United Therapeutics | 21.47 Bn | 18.80 Bn | 683.80 Mn | 6.97 Bn |
| 10 | Clene | 45.69 Mn | 45.69 Mn | 54,000.00 | 20.59 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 20.59 Mn |
| Dec 31, 2025 | 20.22 Mn |
| Sep 30, 2025 | 22.22 Mn |
| Jun 30, 2025 | 23.72 Mn |
| Mar 31, 2025 | 26.33 Mn |
| Dec 31, 2024 | 29.45 Mn |
| Sep 30, 2024 | 35.95 Mn |
| Jun 30, 2024 | 42.70 Mn |
| Mar 31, 2024 | 48.71 Mn |
| Dec 31, 2023 | 56.39 Mn |
| Sep 30, 2023 | 64.14 Mn |
| Jun 30, 2023 | 53.87 Mn |
| Mar 31, 2023 | 42.19 Mn |
| Dec 31, 2022 | 40.25 Mn |
| Sep 30, 2022 | 40.27 Mn |
| Jun 30, 2022 | 48.95 Mn |
| Mar 31, 2022 | 58.21 Mn |
| Dec 31, 2021 | 68.05 Mn |
| Sep 30, 2021 | 73.16 Mn |
| Jun 30, 2021 | 65.91 Mn |